Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy

Annals of Allergy, Asthma and Immunology

Volumn 77, Issue 3, 1996, Pages 203-208

  Ohashi, Yoshihiro ^a   Nakai, Yoshiaki ^a   Sakamoto, Hirokazu ^a   Ohno, Yoshiharu ^a   Sugiura, Yoshikazu ^a   Okamoto, Hideki ^a   Tanaka, Ayaki ^a   Kakinoki, Yasushi ^a   Kishimoto, Kazuya ^a   Hayashi, Motoyo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 2 RECEPTOR;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PERENNIAL RHINITIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION;

EID: 10144250995     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63256-5     Document Type: Article

References (20)

1. Morgan DA, Ruscetti FW, Gallo RC. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 1976;193:1007-8.
2. + T lymphocytes. J Immunol 1982; 129:1076-9.
3. Farrar JJ, Benjamin WR, Hilfker ML, et al. The biochemistry, biology and role of interleukin-2 in the induction of cytotoxic T cell antibody-forming B cell responses. Immunol Rev 1982;63: 129-66.
4. Wladmann TA. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation. Environ Health Perspect 1987;75:11-5.
5. Robb RJ, Munck A, Smith KA. T cell growth factor receptors. Quantitation, specificity and biological relevance. J Exp Med 1981;154:1455-74.
6. Rubin LA, Kurman CC, Fritz ME, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135:3172-7.
7. Pui CH. Serum interleukin-2 receptor: clinical and biological implications. Leukemia 1989;3:323-404.
8. Kahaleh MB, Le Roy EC. Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration. Ann Intern Med 1989;110:446-50.
9. Balderas RS. Elevated titers of cell-free interleukin 2 receptor in serum of lupus mice. J Immunol 1987;139: 1496-50.
10. Kay AB. T lymphocytes and their products in atopic allergy and asthma. Int Arch Allergy Appl Immunol 1991; 94:189-93.
11. Corrigan CJ, Hartnell A, Kay AB. T lymphocyte activation in acute severe asthma. Lancet 1988;i:1129-32.
12. Okuda M, Ishikawa T, Saito Y, et al. A clinical evaluation of N′-5 with perennial-type allergic rhinitis. A test by multi-clinic, intergroup, doubleblind comparative method. Ann Allergy 1984;53:178-85.
13. Chilosi M, Semenzato G, Cetto G, et al. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant α-interferon therapy on clinical parameters and natural killer in vitro activity. Blood 1987;70: 1530-5.
14. Matsumoto T, Miike T, Yamaguchi K, et al. Serum levels of soluble IL-2 receptors, JL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp Immunol 1991;85:288-92.
15. Guarnaccia S, Kurman CCK, Notarangelo LD, et al. Serum soluble interleukin-2 receptor (IL-2R) in children with allergic disorders. Ann Allergy 1993;71:259-62.
16. Brown PH, Crompton GK, Greening AP. Proinflammatory cytokines in acute asthma. Lancet 1991;338:590-3.
17. Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma. Am Rev Respir Dis 1990:141:970-7.
18. Hsieh KH, Wu LH. Decreased expression of high affinity interleukin 2 receptors after hyposensitization to house dust. Ann Allergy 1987;59: 57-62.
19. Tsai LC, Tang RB, Hung MW, et al. Expression of serum IL-2, IL-2R, and CD8 levels during hyposensitization in house-dust-sensitive asthmatics. J Asthma 1990;27:307-13.
20. Malling HJ. Immunotherapy in Europe. Clin Exp Allergy 1994;24: 515-21.